Bolt Biotherapeutics, Inc. reported a net loss of $33.4M in fiscal year 2025. This represents an increase of 47.1% from the prior fiscal year. Over the trailing 12 months, Q3 FY2025 through Q2 FY2026, the same line adds up to a $28.7M net loss. The table below carries 6 fiscal years, from 2020 to 2025, and the quarters Bolt Biotherapeutics, Inc. has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
BOLT Net Income by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
TTM is the trailing twelve months, Q3 FY2025 through Q2 FY2026, summed from the four most recent quarterly filings.
BOLT Net Income by Quarter
Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.
What net income means
Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line.
More Bolt Biotherapeutics, Inc. financials
Frequently Asked Questions
What was Bolt Biotherapeutics, Inc.'s net income in fiscal year 2025?
Bolt Biotherapeutics, Inc. reported a net loss of $33.4M in fiscal year 2025.
How fast is Bolt Biotherapeutics, Inc.'s net income growing?
Bolt Biotherapeutics, Inc. (BOLT) net income rose by 47.1% year over year, from -$63.1M to -$33.4M in fiscal year 2025.
What is Bolt Biotherapeutics, Inc.'s net income over the last twelve months?
Bolt Biotherapeutics, Inc. (BOLT) reported a $28.7M net loss over the trailing 12 months, Q3 FY2025 through Q2 FY2026, summed from the four most recent quarterly filings.
How has Bolt Biotherapeutics, Inc.'s net income changed over the years?
Across the 6 fiscal years this page covers, Bolt Biotherapeutics, Inc. (BOLT) net income went from -$60.7M in fiscal year 2020 to -$33.4M in fiscal year 2025.
What was Bolt Biotherapeutics, Inc.'s net income in the most recent quarter?
Bolt Biotherapeutics, Inc. (BOLT) reported -$7.7M in net income in Q2 2026. This represents an increase of 9.8% from the same quarter a year earlier.
What does net income mean on a financial statement?
Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line. This page lists what Bolt Biotherapeutics, Inc. (BOLT) reported on that line in every period on record.